Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer

Murray, L orcid.org/0000-0003-0658-6455, Mason, J, Henry, AM orcid.org/0000-0002-5379-6618 et al. (4 more authors) (2016) Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer. Radiotherapy and Oncology, 120 (2). pp. 293-299. ISSN 0167-8140

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016, Published by Elsevier Ireland Ltd. All rights reserved. This is an author produced version of a paper published in Radiotherapy and Oncology. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: High dose rate brachytherapy; Localised prostate cancer; Low dose rate brachytherapy; Second cancer risks
Dates:
  • Accepted: 19 May 2016
  • Published (online): 29 June 2016
  • Published: August 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 23 Jun 2016 12:09
Last Modified: 01 Jul 2017 07:24
Published Version: http://dx.doi.org/10.1016/j.radonc.2016.05.026
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.radonc.2016.05.026

Share / Export

Statistics